Georgia Eliminates THC Cap, Expands Medical Cannabis Access

Georgia Gov. Brian Kemp signed legislation Tuesday that removes the state's 5% THC limit on medical cannabis products and broadens access to thousands of additional patients.

The bipartisan measure, which cleared the state legislature in March, marks the most significant expansion of Georgia's medical cannabis program since its creation. The law adds autism and lupus to the list of qualifying conditions and authorizes two new product forms: THC-infused gummies and cannabis flower.

Georgia's medical cannabis program has operated under strict limitations since lawmakers first approved low-THC oil in 2015. The 5% THC cap—among the lowest in states with medical programs—forced patients to use higher volumes of product to achieve therapeutic effects, driving up costs and limiting treatment options.

What Changed

The new law removes any THC percentage restrictions, aligning Georgia more closely with medical programs in other states. Patients will now be able to access full-strength cannabis oils and tinctures that were previously prohibited.

Adding flower and gummies addresses a long-standing complaint from patients and advocates. Many patients prefer smoking or vaping flower for faster symptom relief, while gummies offer precise dosing and discretion. Both product types have been available in most medical states for years.

The autism and lupus additions could bring thousands of new patients into the program. Georgia already allows medical cannabis for conditions including cancer, Parkinson's disease, multiple sclerosis, and severe seizure disorders.

Industry Impact

Georgia's licensed production facilities stand to benefit substantially from the expanded product lineup and patient base. The state currently licenses two cultivation and production companies, though neither has begun sales due to regulatory delays and legal challenges.

Those companies have invested millions in facilities designed to produce various cannabis products. The THC cap removal and new product authorizations should improve their economic viability once operations begin.

But Georgia's program still faces significant hurdles. Unlike most medical states, Georgia doesn't allow in-state sales of cannabis products. Patients must obtain low-THC oil from out-of-state sources or wait for the state's licensed producers to launch—a timeline that remains unclear.

What's Next

The Georgia Access to Medical Cannabis Commission will need to develop regulations for the new product types and update licensing requirements. The commission hasn't announced a timeline for those rule changes.

Patients with autism or lupus can begin applying for medical cannabis cards once the state updates its registration system to include the new conditions. Georgia requires patients to obtain a recommendation from a physician and register with the state before legally possessing cannabis products.

Advocates have pushed for years to expand Georgia's program beyond low-THC oil. Tuesday's signing represents a partial victory, though many continue to call for full legalization or at least a more robust medical system with in-state dispensaries.

The law takes effect immediately.

---

This article is based on original reporting by ganjapreneur.com.